Vertex Pharmaceuticals (VRTX) Net Income towards Common Stockholders Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.57% |
| Dec 31, 2025 | 14.54% |
| Sep 30, 2025 | 10.16% |
| Jun 30, 2025 | 4.29% |
| Mar 31, 2025 | 1.40% |
| Dec 31, 2024 | 9.38% |
| Sep 30, 2024 | 78.61% |
| Jun 30, 2024 | -72.87% |
| Mar 31, 2024 | 32.56% |
| Dec 31, 2023 | -8.68% |
| Sep 30, 2023 | 59.56% |
| Jun 30, 2023 | 38.82% |
| Mar 31, 2023 | 28.79% |
| Dec 31, 2022 | 56.06% |
| Sep 30, 2022 | 38.35% |
| Jun 30, 2022 | 47.23% |
| Mar 31, 2022 | 62.74% |
| Dec 31, 2021 | 47.60% |
| Sep 30, 2021 | 41.95% |
| Jun 30, 2021 | 18.12% |
| Mar 31, 2021 | 39.83% |
| Dec 31, 2020 | 42.77% |
| Sep 30, 2020 | 44.58% |
| Jun 30, 2020 | 49.48% |
| Mar 31, 2020 | 98.21% |
| Dec 31, 2019 | 96.47% |
| Sep 30, 2019 | 289.87% |
| Jun 30, 2019 | 291.07% |
| Mar 31, 2019 | 278.65% |
| Dec 31, 2018 | 62.47% |
| Sep 30, 2018 | 20.39% |
| Jun 30, 2018 | 24.03% |
| Mar 31, 2018 | 24.57% |
| Dec 31, 2017 | 18.35% |
| Sep 30, 2017 | -62.85% |
| Jun 30, 2017 | -36.74% |
| Mar 31, 2017 | -5.35% |
| Dec 31, 2016 | -24.34% |
| Sep 30, 2016 | -24.85% |
| Mar 31, 2016 | -2.08% |
| Dec 31, 2015 | 3.16% |
| Sep 30, 2015 | 5.85% |
| Jun 30, 2015 | 5.19% |
| Mar 31, 2015 | 33.64% |
| Dec 31, 2014 | 32.35% |
| Sep 30, 2014 | 78.80% |
| Jun 30, 2014 | 71.61% |
| Mar 31, 2014 | 70.79% |